| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Randomized, Double-Blind Trial Comparing the Pharmacokinetics of CT-P16, a Candidate Bevacizumab Biosimilar, with its Reference Product in Healthy Adult Males
|
Cho, Sang-Heon
|
|
2019
|
33 |
2 |
p. 173-181
|
artikel
|
| 2 |
CDK4/6 Inhibitors Expand the Therapeutic Options in Breast Cancer: Palbociclib, Ribociclib and Abemaciclib
|
Eggersmann, Tanja K.
|
|
2019
|
33 |
2 |
p. 125-135
|
artikel
|
| 3 |
Comparative Stability Studies of Different Infliximab and Biosimilar CT-P13 Clinical Solutions by Combined Use of Physicochemical Analytical Techniques and Enzyme-Linked Immunosorbent Assay (ELISA)
|
Hermosilla, Jesús
|
|
2019
|
33 |
2 |
p. 193-205
|
artikel
|
| 4 |
First-Line Treatment of Non-Small-Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors
|
Bylicki, Olivier
|
|
2019
|
33 |
2 |
p. 159-171
|
artikel
|
| 5 |
In-Use Stability of the Rituximab Biosimilar CT-P10 (Truxima®) Following Preparation for Intravenous Infusion and Storage
|
Kim, Su Jung
|
|
2019
|
33 |
2 |
p. 221-228
|
artikel
|
| 6 |
LA-EP2006: A Pegfilgrastim Biosimilar
|
Hoy, Sheridan M.
|
|
2019
|
33 |
2 |
p. 229-232
|
artikel
|
| 7 |
Perspectives of Hospital Pharmacists Towards Biosimilar Medicines: A Survey of Polish Pharmacy Practice in General Hospitals
|
Pawłowska, Iga
|
|
2019
|
33 |
2 |
p. 183-191
|
artikel
|
| 8 |
PF-06881893 (Nivestym™), a Filgrastim Biosimilar, Versus US-Licensed Filgrastim Reference Product (US-Neupogen®): Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy Volunteers
|
Yao, Hsuan-Ming
|
|
2019
|
33 |
2 |
p. 207-220
|
artikel
|
| 9 |
The Relationship between Exosomes and Cancer: Implications for Diagnostics and Therapeutics
|
Weston, Wendy W.
|
|
2019
|
33 |
2 |
p. 137-158
|
artikel
|
| 10 |
Vestronidase Alfa: A Review in Mucopolysaccharidosis VII
|
McCafferty, Emma H.
|
|
2019
|
33 |
2 |
p. 233-240
|
artikel
|
| 11 |
Vestronidase Alfa: A Review in Mucopolysaccharidosis VII
|
McCafferty, Emma H.
|
|
|
33 |
2 |
p. 233-240
|
artikel
|
Tijdschrift beschrijving